Reby Advisors’s Zimmer Biomet ZBH Stock Holding History

Reby Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$15K	Buy	+103	New	+$14.5K	﹤0.01%	383

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Reby Advisors's ZBH Position: Q4 2020 in Review

Reby Advisors opened a new position in Zimmer Biomet (ZBH) in Q4 2020: 103 shares worth $15K. The stake represents ﹤0.01% of the portfolio and ranks #383 among its holdings.

1,011 funds tracked by Wall St. Rank hold ZBH as of Q4 2020.

Reby Advisors held 103 shares of Zimmer Biomet worth $15K as of Q4 2020.
Zimmer Biomet was a new Reby Advisors position in Q4 2020.
Zimmer Biomet made up ﹤0.01% of Reby Advisors's portfolio in Q4 2020, its #383 holding.
1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2020.

Based on Reby Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.